1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Piroxicam Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Suppositories 1.2.3 Injection 1.2.4 Capsule 1.2.5 Patch 1.2.6 Other 1.3 Market by Application 1.3.1 Global Piroxicam Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Tendonitis 1.3.3 Systemic Traumatic Pain 1.3.4 Musculoskeletal Pain 1.3.5 Contraception 1.3.6 Rheumatoid Arthritis 1.3.7 Chronic Infectious Arthritis 1.3.8 Osteoarthritis 1.3.9 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Piroxicam Market Perspective (2016-2027) 2.2 Piroxicam Growth Trends by Regions 2.2.1 Piroxicam Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Piroxicam Historic Market Share by Regions (2016-2021) 2.2.3 Piroxicam Forecasted Market Size by Regions (2022-2027) 2.3 Piroxicam Industry Dynamic 2.3.1 Piroxicam Market Trends 2.3.2 Piroxicam Market Drivers 2.3.3 Piroxicam Market Challenges 2.3.4 Piroxicam Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Piroxicam Players by Revenue 3.1.1 Global Top Piroxicam Players by Revenue (2016-2021) 3.1.2 Global Piroxicam Revenue Market Share by Players (2016-2021) 3.2 Global Piroxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Piroxicam Revenue 3.4 Global Piroxicam Market Concentration Ratio 3.4.1 Global Piroxicam Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Piroxicam Revenue in 2020 3.5 Piroxicam Key Players Head office and Area Served 3.6 Key Players Piroxicam Product Solution and Service 3.7 Date of Enter into Piroxicam Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Piroxicam Breakdown Data by Type 4.1 Global Piroxicam Historic Market Size by Type (2016-2021) 4.2 Global Piroxicam Forecasted Market Size by Type (2022-2027) 5 Piroxicam Breakdown Data by Application 5.1 Global Piroxicam Historic Market Size by Application (2016-2021) 5.2 Global Piroxicam Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Piroxicam Market Size (2016-2027) 6.2 North America Piroxicam Market Size by Type 6.2.1 North America Piroxicam Market Size by Type (2016-2021) 6.2.2 North America Piroxicam Market Size by Type (2022-2027) 6.2.3 North America Piroxicam Market Size by Type (2016-2027) 6.3 North America Piroxicam Market Size by Application 6.3.1 North America Piroxicam Market Size by Application (2016-2021) 6.3.2 North America Piroxicam Market Size by Application (2022-2027) 6.3.3 North America Piroxicam Market Size by Application (2016-2027) 6.4 North America Piroxicam Market Size by Country 6.4.1 North America Piroxicam Market Size by Country (2016-2021) 6.4.2 North America Piroxicam Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Piroxicam Market Size (2016-2027) 7.2 Europe Piroxicam Market Size by Type 7.2.1 Europe Piroxicam Market Size by Type (2016-2021) 7.2.2 Europe Piroxicam Market Size by Type (2022-2027) 7.2.3 Europe Piroxicam Market Size by Type (2016-2027) 7.3 Europe Piroxicam Market Size by Application 7.3.1 Europe Piroxicam Market Size by Application (2016-2021) 7.3.2 Europe Piroxicam Market Size by Application (2022-2027) 7.3.3 Europe Piroxicam Market Size by Application (2016-2027) 7.4 Europe Piroxicam Market Size by Country 7.4.1 Europe Piroxicam Market Size by Country (2016-2021) 7.4.2 Europe Piroxicam Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Piroxicam Market Size (2016-2027) 8.2 Asia-Pacific Piroxicam Market Size by Type 8.2.1 Asia-Pacific Piroxicam Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Piroxicam Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Piroxicam Market Size by Type (2016-2027) 8.3 Asia-Pacific Piroxicam Market Size by Application 8.3.1 Asia-Pacific Piroxicam Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Piroxicam Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Piroxicam Market Size by Application (2016-2027) 8.4 Asia-Pacific Piroxicam Market Size by Region 8.4.1 Asia-Pacific Piroxicam Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Piroxicam Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Piroxicam Market Size (2016-2027) 9.2 Latin America Piroxicam Market Size by Type 9.2.1 Latin America Piroxicam Market Size by Type (2016-2021) 9.2.2 Latin America Piroxicam Market Size by Type (2022-2027) 9.2.3 Latin America Piroxicam Market Size by Type (2016-2027) 9.3 Latin America Piroxicam Market Size by Application 9.3.1 Latin America Piroxicam Market Size by Application (2016-2021) 9.3.2 Latin America Piroxicam Market Size by Application (2022-2027) 9.3.3 Latin America Piroxicam Market Size by Application (2016-2027) 9.4 Latin America Piroxicam Market Size by Country 9.4.1 Latin America Piroxicam Market Size by Country (2016-2021) 9.4.2 Latin America Piroxicam Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Piroxicam Market Size (2016-2027) 10.2 Middle East & Africa Piroxicam Market Size by Type 10.2.1 Middle East & Africa Piroxicam Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Piroxicam Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Piroxicam Market Size by Type (2016-2027) 10.3 Middle East & Africa Piroxicam Market Size by Application 10.3.1 Middle East & Africa Piroxicam Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Piroxicam Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Piroxicam Market Size by Application (2016-2027) 10.4 Middle East & Africa Piroxicam Market Size by Country 10.4.1 Middle East & Africa Piroxicam Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Piroxicam Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Piroxicam Introduction 11.1.4 Pfizer Revenue in Piroxicam Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Teva 11.2.1 Teva Company Details 11.2.2 Teva Business Overview 11.2.3 Teva Piroxicam Introduction 11.2.4 Teva Revenue in Piroxicam Business (2016-2021) 11.2.5 Teva Recent Development 11.3 Mylan 11.3.1 Mylan Company Details 11.3.2 Mylan Business Overview 11.3.3 Mylan Piroxicam Introduction 11.3.4 Mylan Revenue in Piroxicam Business (2016-2021) 11.3.5 Mylan Recent Development 11.4 Nostrum 11.4.1 Nostrum Company Details 11.4.2 Nostrum Business Overview 11.4.3 Nostrum Piroxicam Introduction 11.4.4 Nostrum Revenue in Piroxicam Business (2016-2021) 11.4.5 Nostrum Recent Development 11.5 DCPC 11.5.1 DCPC Company Details 11.5.2 DCPC Business Overview 11.5.3 DCPC Piroxicam Introduction 11.5.4 DCPC Revenue in Piroxicam Business (2016-2021) 11.5.5 DCPC Recent Development 11.6 FANGMING 11.6.1 FANGMING Company Details 11.6.2 FANGMING Business Overview 11.6.3 FANGMING Piroxicam Introduction 11.6.4 FANGMING Revenue in Piroxicam Business (2016-2021) 11.6.5 FANGMING Recent Development 11.7 JINGHUA 11.7.1 JINGHUA Company Details 11.7.2 JINGHUA Business Overview 11.7.3 JINGHUA Piroxicam Introduction 11.7.4 JINGHUA Revenue in Piroxicam Business (2016-2021) 11.7.5 JINGHUA Recent Development 11.8 JUMPCAN 11.8.1 JUMPCAN Company Details 11.8.2 JUMPCAN Business Overview 11.8.3 JUMPCAN Piroxicam Introduction 11.8.4 JUMPCAN Revenue in Piroxicam Business (2016-2021) 11.8.5 JUMPCAN Recent Development 11.9 Technilab Pharma 11.9.1 Technilab Pharma Company Details 11.9.2 Technilab Pharma Business Overview 11.9.3 Technilab Pharma Piroxicam Introduction 11.9.4 Technilab Pharma Revenue in Piroxicam Business (2016-2021) 11.9.5 Technilab Pharma Recent Development 11.10 Apotex Corporation 11.10.1 Apotex Corporation Company Details 11.10.2 Apotex Corporation Business Overview 11.10.3 Apotex Corporation Piroxicam Introduction 11.10.4 Apotex Corporation Revenue in Piroxicam Business (2016-2021) 11.10.5 Apotex Corporation Recent Development 11.11 Keltman Pharmaceuticals 11.11.1 Keltman Pharmaceuticals Company Details 11.11.2 Keltman Pharmaceuticals Business Overview 11.11.3 Keltman Pharmaceuticals Piroxicam Introduction 11.11.4 Keltman Pharmaceuticals Revenue in Piroxicam Business (2016-2021) 11.11.5 Keltman Pharmaceuticals Recent Development 11.12 Genpharm 11.12.1 Genpharm Company Details 11.12.2 Genpharm Business Overview 11.12.3 Genpharm Piroxicam Introduction 11.12.4 Genpharm Revenue in Piroxicam Business (2016-2021) 11.12.5 Genpharm Recent Development 11.13 Bayer 11.13.1 Bayer Company Details 11.13.2 Bayer Business Overview 11.13.3 Bayer Piroxicam Introduction 11.13.4 Bayer Revenue in Piroxicam Business (2016-2021) 11.13.5 Bayer Recent Development 11.14 PLX Pharma 11.14.1 PLX Pharma Company Details 11.14.2 PLX Pharma Business Overview 11.14.3 PLX Pharma Piroxicam Introduction 11.14.4 PLX Pharma Revenue in Piroxicam Business (2016-2021) 11.14.5 PLX Pharma Recent Development 11.15 Chiesi 11.15.1 Chiesi Company Details 11.15.2 Chiesi Business Overview 11.15.3 Chiesi Piroxicam Introduction 11.15.4 Chiesi Revenue in Piroxicam Business (2016-2021) 11.15.5 Chiesi Recent Development 11.16 SK Chemicals 11.16.1 SK Chemicals Company Details 11.16.2 SK Chemicals Business Overview 11.16.3 SK Chemicals Piroxicam Introduction 11.16.4 SK Chemicals Revenue in Piroxicam Business (2016-2021) 11.16.5 SK Chemicals Recent Development 11.17 Bioglan Laboratories 11.17.1 Bioglan Laboratories Company Details 11.17.2 Bioglan Laboratories Business Overview 11.17.3 Bioglan Laboratories Piroxicam Introduction 11.17.4 Bioglan Laboratories Revenue in Piroxicam Business (2016-2021) 11.17.5 Bioglan Laboratories Recent Development 11.18 APR 11.18.1 APR Company Details 11.18.2 APR Business Overview 11.18.3 APR Piroxicam Introduction 11.18.4 APR Revenue in Piroxicam Business (2016-2021) 11.18.5 APR Recent Development 11.18 CJ HealthCare .1 CJ HealthCare Company Details .2 CJ HealthCare Business Overview .3 CJ HealthCare Piroxicam Introduction .4 CJ HealthCare Revenue in Piroxicam Business (2016-2021) .5 CJ HealthCare Recent Development 11.20 SkyePharma 11.20.1 SkyePharma Company Details 11.20.2 SkyePharma Business Overview 11.20.3 SkyePharma Piroxicam Introduction 11.20.4 SkyePharma Revenue in Piroxicam Business (2016-2021) 11.20.5 SkyePharma Recent Development 11.21 Changzhou Siyao Pharmaceutical 11.21.1 Changzhou Siyao Pharmaceutical Company Details 11.21.2 Changzhou Siyao Pharmaceutical Business Overview 11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Introduction 11.21.4 Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2016-2021) 11.21.5 Changzhou Siyao Pharmaceutical Recent Development 11.22 Shanxi Yunpeng Pharmaceutical 11.22.1 Shanxi Yunpeng Pharmaceutical Company Details 11.22.2 Shanxi Yunpeng Pharmaceutical Business Overview 11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Introduction 11.22.4 Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2016-2021) 11.22.5 Shanxi Yunpeng Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Piroxicam Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Suppositories Table 3. Key Players of Injection Table 4. Key Players of Capsule Table 5. Key Players of Patch Table 6. Key Players of Other Table 7. Global Piroxicam Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Piroxicam Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Piroxicam Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Piroxicam Market Share by Regions (2016-2021) Table 11. Global Piroxicam Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Piroxicam Market Share by Regions (2022-2027) Table 13. Piroxicam Market Trends Table 14. Piroxicam Market Drivers Table 15. Piroxicam Market Challenges Table 16. Piroxicam Market Restraints Table 17. Global Piroxicam Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Piroxicam Market Share by Players (2016-2021) Table 19. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piroxicam as of 2020) Table 20. Ranking of Global Top Piroxicam Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Piroxicam Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Piroxicam Product Solution and Service Table 24. Date of Enter into Piroxicam Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Piroxicam Market Size by Type (2016-2021) (US$ Million) Table 27. Global Piroxicam Revenue Market Share by Type (2016-2021) Table 28. Global Piroxicam Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Piroxicam Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Piroxicam Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Piroxicam Revenue Market Share by Application (2016-2021) Table 32. Global Piroxicam Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Piroxicam Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Piroxicam Market Size by Type (2016-2021) (US$ Million) Table 35. North America Piroxicam Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Piroxicam Market Size by Application (2016-2021) (US$ Million) Table 37. North America Piroxicam Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Piroxicam Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Piroxicam Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Piroxicam Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Piroxicam Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Piroxicam Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Piroxicam Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Piroxicam Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Piroxicam Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Piroxicam Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Piroxicam Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Piroxicam Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Piroxicam Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Piroxicam Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Piroxicam Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Piroxicam Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Piroxicam Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Piroxicam Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Piroxicam Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Piroxicam Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Piroxicam Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Piroxicam Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Piroxicam Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Piroxicam Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Piroxicam Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Piroxicam Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Piroxicam Market Size by Country (2022-2027) & (US$ Million) Table 64. Pfizer Company Details Table 65. Pfizer Business Overview Table 66. Pfizer Piroxicam Product Table 67. Pfizer Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 68. Pfizer Recent Development Table 69. Teva Company Details Table 70. Teva Business Overview Table 71. Teva Piroxicam Product Table 72. Teva Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 73. Teva Recent Development Table 74. Mylan Company Details Table 75. Mylan Business Overview Table 76. Mylan Piroxicam Product Table 77. Mylan Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 78. Mylan Recent Development Table 79. Nostrum Company Details Table 80. Nostrum Business Overview Table 81. Nostrum Piroxicam Product Table 82. Nostrum Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 83. Nostrum Recent Development Table 84. DCPC Company Details Table 85. DCPC Business Overview Table 86. DCPC Piroxicam Product Table 87. DCPC Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 88. DCPC Recent Development Table 89. FANGMING Company Details Table 90. FANGMING Business Overview Table 91. FANGMING Piroxicam Product Table 92. FANGMING Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 93. FANGMING Recent Development Table 94. JINGHUA Company Details Table 95. JINGHUA Business Overview Table 96. JINGHUA Piroxicam Product Table 97. JINGHUA Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 98. JINGHUA Recent Development Table 99. JUMPCAN Company Details Table 100. JUMPCAN Business Overview Table 101. JUMPCAN Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 102. JUMPCAN Recent Development Table 103. Technilab Pharma Company Details Table 104. Technilab Pharma Business Overview Table 105. Technilab Pharma Piroxicam Product Table 106. Technilab Pharma Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 107. Technilab Pharma Recent Development Table 108. Apotex Corporation Company Details Table 109. Apotex Corporation Business Overview Table 110. Apotex Corporation Piroxicam Product Table 111. Apotex Corporation Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 112. Apotex Corporation Recent Development Table 113. Keltman Pharmaceuticals Company Details Table 114. Keltman Pharmaceuticals Business Overview Table 115. Keltman Pharmaceuticals Piroxicam Product Table 116. Keltman Pharmaceuticals Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 117. Keltman Pharmaceuticals Recent Development Table 118. Genpharm Company Details Table 119. Genpharm Business Overview Table 120. Genpharm Piroxicam Product Table 121. Genpharm Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 122. Genpharm Recent Development Table 123. Bayer Company Details Table 124. Bayer Business Overview Table 125. Bayer Piroxicam Product Table 126. Bayer Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 127. Bayer Recent Development Table 128. PLX Pharma Company Details Table 129. PLX Pharma Business Overview Table 130. PLX Pharma Piroxicam Product Table 131. PLX Pharma Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 132. PLX Pharma Recent Development Table 133. Chiesi Company Details Table 134. Chiesi Business Overview Table 135. Chiesi Piroxicam Product Table 136. Chiesi Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 137. Chiesi Recent Development Table 138. SK Chemicals Company Details Table 139. SK Chemicals Business Overview Table 140. SK Chemicals Piroxicam Product Table 141. SK Chemicals Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 142. SK Chemicals Recent Development Table 143. Bioglan Laboratories Company Details Table 144. Bioglan Laboratories Business Overview Table 145. Bioglan Laboratories Piroxicam Product Table 146. Bioglan Laboratories Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 147. Bioglan Laboratories Recent Development Table 148. APR Company Details Table 149. APR Business Overview Table 150. APR Piroxicam Product Table 151. APR Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 152. APR Recent Development Table 153. CJ HealthCare Company Details Table 154. CJ HealthCare Business Overview Table 155. CJ HealthCare Piroxicam Product Table 156. CJ HealthCare Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 157. CJ HealthCare Recent Development Table 158. SkyePharma Company Details Table 159. SkyePharma Business Overview Table 160. SkyePharma Piroxicam Product Table 161. SkyePharma Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 162. SkyePharma Recent Development Table 163. Changzhou Siyao Pharmaceutical Company Details Table 164. Changzhou Siyao Pharmaceutical Business Overview Table 165. Changzhou Siyao Pharmaceutical Piroxicam Product Table 166. Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 167. Changzhou Siyao Pharmaceutical Recent Development Table 168. Shanxi Yunpeng Pharmaceutical Company Details Table 169. Shanxi Yunpeng Pharmaceutical Business Overview Table 170. Shanxi Yunpeng Pharmaceutical Piroxicam Product Table 171. Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2016-2021) & (US$ Million) Table 172. Shanxi Yunpeng Pharmaceutical Recent Development Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Global Piroxicam Market Share by Type: 2020 VS 2027 Figure 2. Suppositories Features Figure 3. Injection Features Figure 4. Capsule Features Figure 5. Patch Features Figure 6. Other Features Figure 7. Global Piroxicam Market Share by Application: 2020 VS 2027 Figure 8. Tendonitis Case Studies Figure 9. Systemic Traumatic Pain Case Studies Figure 10. Musculoskeletal Pain Case Studies Figure 11. Contraception Case Studies Figure 12. Rheumatoid Arthritis Case Studies Figure 13. Chronic Infectious Arthritis Case Studies Figure 14. Osteoarthritis Case Studies Figure 15. Other Case Studies Figure 16. Piroxicam Report Years Considered Figure 17. Global Piroxicam Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 18. Global Piroxicam Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Piroxicam Market Share by Regions: 2020 VS 2027 Figure 20. Global Piroxicam Market Share by Regions (2022-2027) Figure 21. Global Piroxicam Market Share by Players in 2020 Figure 22. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piroxicam as of 2020 Figure 23. The Top 10 and 5 Players Market Share by Piroxicam Revenue in 2020 Figure 24. Global Piroxicam Revenue Market Share by Type (2016-2021) Figure 25. Global Piroxicam Revenue Market Share by Type (2022-2027) Figure 26. North America Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. North America Piroxicam Market Share by Type (2016-2027) Figure 28. North America Piroxicam Market Share by Application (2016-2027) Figure 29. North America Piroxicam Market Share by Country (2016-2027) Figure 30. United States Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Canada Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Piroxicam Market Share by Type (2016-2027) Figure 34. Europe Piroxicam Market Share by Application (2016-2027) Figure 35. Europe Piroxicam Market Share by Country (2016-2027) Figure 36. Germany Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. France Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. U.K. Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Italy Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Russia Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Nordic Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Piroxicam Market Share by Type (2016-2027) Figure 44. Asia-Pacific Piroxicam Market Share by Application (2016-2027) Figure 45. Asia-Pacific Piroxicam Market Share by Region (2016-2027) Figure 46. China Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Japan Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. South Korea Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Southeast Asia Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. India Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Australia Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Piroxicam Market Share by Type (2016-2027) Figure 54. Latin America Piroxicam Market Share by Application (2016-2027) Figure 55. Latin America Piroxicam Market Share by Country (2016-2027) Figure 56. Mexico Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Brazil Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Piroxicam Market Share by Type (2016-2027) Figure 60. Middle East & Africa Piroxicam Market Share by Application (2016-2027) Figure 61. Middle East & Africa Piroxicam Market Share by Country (2016-2027) Figure 62. Turkey Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Saudi Arabia Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. UAE Piroxicam Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. Pfizer Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 66. Teva Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 67. Mylan Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 68. Nostrum Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 69. DCPC Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 70. FANGMING Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 71. JINGHUA Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 72. JUMPCAN Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 73. Technilab Pharma Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 74. Apotex Corporation Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 75. Keltman Pharmaceuticals Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 76. Genpharm Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 77. Bayer Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 78. PLX Pharma Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 79. Chiesi Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 80. SK Chemicals Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 81. Bioglan Laboratories Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 82. APR Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 83. CJ HealthCare Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 84. SkyePharma Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 85. Changzhou Siyao Pharmaceutical Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 86. Shanxi Yunpeng Pharmaceutical Revenue Growth Rate in Piroxicam Business (2016-2021) Figure 87. Bottom-up and Top-down Approaches for This Report Figure 88. Data Triangulation Figure 89. Key Executives Interviewed

Pfizer Teva Mylan Nostrum DCPC FANGMING JINGHUA JUMPCAN Technilab Pharma Apotex Corporation Keltman Pharmaceuticals Genpharm Bayer PLX Pharma Chiesi SK Chemicals Bioglan Laboratories APR CJ HealthCare SkyePharma Changzhou Siyao Pharmaceutical Shanxi Yunpeng Pharmaceutical